Palm Beach Institute of Hematology and Oncology

Boynton Beach, Florida 33435

0 studies enrolling now · 10 studies all time

What they study most

Adenocarcinoma, Advanced Carcinoma, Breast Cancer, Breast Neoplasms, Carcinoma, Pancreatic Ductal, Chemotherapy-Induced Nausea and Vomiting, Chronic Lymphocytic Leukemia, Neoplasm Metastasis, Non-small Cell Lung Cancer, Ovarian Cancer, Pancreatic Cancer, Pancreatic Disease

Studies at this site

• Efficacy and Safety of Farletuzumab (MORAb-003) in Combination With Carboplatin and Taxane in Participants With Platinum-sensitive Ovarian Cancer in First Relapse — Stopped early
• A Study of Aflibercept Administered in Combination With Pemetrexed and Cisplatin in Participants With Advanced Carcinoma — Stopped early
• Weekly vs. Every 2 Week vs. Every 3 Week Administration of ABI-007 (Abraxane)/Bevacizumab Combination in Metastatic Breast Cancer — Stopped early
• Study Evaluating Neratinib Plus Paclitaxel VS Trastuzumab Plus Paclitaxel In ErbB-2 Positive Advanced Breast Cancer — Completed
• A Study of AGS-1C4D4 Given in Combination With Gemcitabine in Subjects With Metastatic Pancreatic Cancer — Completed
• An Efficacy Study of MORAb-009 in Subjects With Pancreatic Cancer — Completed
• An Efficacy and Safety Study of Oral Netupitant and Palonosetron for the Prevention of Nausea and Vomiting — Completed
• Study of the Efficacy and Safety of Glufosfamide Compared With Best Supportive Care in Metastatic Pancreatic Cancer — Completed
• Trial of Talabostat and Gemcitabine in Patients With Stage IV Adenocarcinoma of the Pancreas — Stopped early
• Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia. — Status unconfirmed